Dr. David Cowburn's lab at the Albert Einstein College of Medicine explores how the dynamic behaviors of disordered proteins influence their roles in various biological processes. By employing advanced techniques like NMR spectroscopy and molecular simulations, the lab is focusing on the nuclear pore complex and the engineering of proteins through inteins for therapeutic applications. This research is significant for understanding diseases like cancer and neurodegeneration, and may lead to new methods for targeted drug delivery.

Dr. Jonathan R. Lai's lab at Albert Einstein College of Medicine focuses on developing immunotherapies using human antibodies to combat alphavirus infections, such as Chikungunya and Mayaro viruses. The lab studies how these viruses cause diseases like arthritis and seeks to create effective antibody combinations to enhance protection against these viral infections. Their research could lead to new therapeutic options for patients suffering from alphavirus-related illnesses.

Dr. Vern L. Schramm's lab focuses on developing targeted therapies for cancer based on understanding the mechanisms of enzymes involved in cell death. By studying specific enzymes, such as SAMHD1 and PNP, the lab aims to create effective drug combinations that can improve treatment outcomes for T-cell cancers. The research combines principles of chemistry and biology to design inhibitors that may help patients with resistant cancers.